SEC Filing Analysis: Surrozen, Inc./DE (SRZN)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The CEO acquired a small number of shares through a routine Employee Stock Purchase Plan (ESPP).
• Market Impact: Negligible, given the transaction's small size relative to the company's market capitalization.

Company Information

Field	Value
Company	Surrozen, Inc./DE
Ticker Symbol	SRZN
CIK	0001824893
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Parker Craig C
CIK	0001526064
Title/Position	Chief Executive Officer
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-15
Transaction Code	A
Security Type	Common Stock
Shares Involved	1,553
Price Per Share	$8.11
Total Value	$12,594.83
Shares Owned After	8,577
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$12,594.83
% of Market Cap	0.011%
Shares Transacted	1,553
% of Shares Outstanding	Not Available
Post-Transaction Ownership	8,577 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value of approximately $12.6k is insignificant against Surrozen's $110 million market capitalization.
• Transaction Significance: This is a routine, programmatic acquisition through an ESPP, which typically does not signal a change in insider sentiment. The value is well below any threshold for materiality.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is a small, pre-planned acquisition via an ESPP, not a discretionary open-market purchase. It carries no new information for the market.

Volume & Sentiment

• Expected Volume Impact: None. The transaction is too small to affect trading volume.
• Sentiment Indicator: Neutral. ESPP purchases are common and not considered a bullish or bearish signal.

Additional Context

Transaction Notes

• Special Circumstances: The filing footnote explicitly states the shares were acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan and were exempt under Rule 16b-3.